Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer.
Landi L, D'Incà F, Gelibter A, Chiari R, Grossi F, Delmonte A, Passaro A, Signorelli D, Gelsomino F, Galetta D, Giannarelli D, Soto Parra H, Minuti G, Tiseo M, Migliorino MR, Cognetti F, Toschi L, Bidoli P, Piantedosi F, Calabro' L, Cappuzzo F. Landi L, et al. Among authors: d inca f. J Immunother Cancer. 2019 Nov 21;7(1):316. doi: 10.1186/s40425-019-0793-8. J Immunother Cancer. 2019. PMID: 31752994 Free PMC article.
Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial.
Landi L, Chiari R, Tiseo M, D'Incà F, Dazzi C, Chella A, Delmonte A, Bonanno L, Giannarelli D, Cortinovis DL, de Marinis F, Borra G, Morabito A, Gridelli C, Galetta D, Barbieri F, Grossi F, Capelletto E, Minuti G, Mazzoni F, Verusio C, Bria E, Alì G, Bruno R, Proietti A, Fontanini G, Crinò L, Cappuzzo F. Landi L, et al. Among authors: d inca f. Clin Cancer Res. 2019 Dec 15;25(24):7312-7319. doi: 10.1158/1078-0432.CCR-19-0994. Epub 2019 Aug 15. Clin Cancer Res. 2019. PMID: 31416808 Clinical Trial.
Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC).
Vecchiarelli S, Passiglia F, D'Incecco A, Gallo M, De Luca A, Rossi E, D'Incà F, Minuti G, Landi L, Bennati C, Spreafico M, D'Arcangelo M, Mazza V, Normanno N, Cappuzzo F. Vecchiarelli S, et al. Among authors: d inca f. Oncotarget. 2018 Apr 3;9(25):17554-17563. doi: 10.18632/oncotarget.24785. eCollection 2018 Apr 3. Oncotarget. 2018. PMID: 29707129 Free PMC article.
Mast cell: an emerging partner in immune interaction.
Gri G, Frossi B, D'Inca F, Danelli L, Betto E, Mion F, Sibilano R, Pucillo C. Gri G, et al. Among authors: d inca f. Front Immunol. 2012 May 25;3:120. doi: 10.3389/fimmu.2012.00120. eCollection 2012. Front Immunol. 2012. PMID: 22654879 Free PMC article.
Mast cells control the expansion and differentiation of IL-10-competent B cells.
Mion F, D'Incà F, Danelli L, Toffoletto B, Guarnotta C, Frossi B, Burocchi A, Rigoni A, Gerdes N, Lutgens E, Tripodo C, Colombo MP, Rivera J, Vitale G, Pucillo CE. Mion F, et al. Among authors: d inca f. J Immunol. 2014 Nov 1;193(9):4568-79. doi: 10.4049/jimmunol.1302593. Epub 2014 Sep 29. J Immunol. 2014. PMID: 25267976
Exosomes: tiny clues for mast cell communication.
D'Incà F, Pucillo CE. D'Incà F, et al. Front Immunol. 2015 Feb 18;6:73. doi: 10.3389/fimmu.2015.00073. eCollection 2015. Front Immunol. 2015. PMID: 25741344 Free PMC article. Review. No abstract available.
Single-cell dynamics of mast cell-CD4+ CD25+ regulatory T cell interactions.
Frossi B, D'Incà F, Crivellato E, Sibilano R, Gri G, Mongillo M, Danelli L, Maggi L, Pucillo CE. Frossi B, et al. Among authors: d inca f. Eur J Immunol. 2011 Jul;41(7):1872-82. doi: 10.1002/eji.201041300. Epub 2011 Jun 8. Eur J Immunol. 2011. PMID: 21509780 Free article.